Features & Capabilities

This program discusses relapsed/refractory multiple myeloma and role of BCMA therapies

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.

User Growth & Download Statistics

App
By:
Med Learning Group
Version:
1.0 Last updated: 2023-05-26
Version code:
857364449
Creation date:
2023-05-26
Compatible devices:
Size:
89.88MB
URLs:
Privacy policy
Full description:
See detailed description
Source:
Apple Apps Store
Data ingested on:
2026-06-08
Compare stats and ranking:

Contact the developer

Chrome-Stats does not own this Apple app. Please use these information below to contact the Apple app developer.
Developed by:
Med Learning Group
Apple Apps Store
https://apps.apple.com/us/app/multiple-myeloma-management/id6449560414

Best Multiple Myeloma Management Alternatives

Here are some Apple apps that are similar to Multiple Myeloma Management: